XML 24 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONSOLIDATED BALANCE SHEETS (UNAUDITED) (USD $)
Jan. 31, 2015
Jul. 31, 2014
ASSETS    
Cash and cash equivalents $ 1,609,867us-gaap_CashAndCashEquivalentsAtCarryingValue $ 3,269,489us-gaap_CashAndCashEquivalentsAtCarryingValue
Other current assets 99,775us-gaap_OtherAssetsCurrent 201,314us-gaap_OtherAssetsCurrent
Total Current Assets 1,709,642us-gaap_AssetsCurrent 3,470,803us-gaap_AssetsCurrent
Property and Equipment, Net 3,743us-gaap_PropertyPlantAndEquipmentNet 5,293us-gaap_PropertyPlantAndEquipmentNet
Patents, Net 1,882,819us-gaap_FiniteLivedIntangibleAssetsNet 2,046,361us-gaap_FiniteLivedIntangibleAssetsNet
TOTAL ASSETS 3,596,204us-gaap_Assets 5,522,457us-gaap_Assets
LIABILITIES AND STOCKHOLDERS' DEFICIENCY    
Accounts payable and accrued expenses (Note 5) 7,534,169us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent 8,034,122us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Deferred revenue 223,662us-gaap_DeferredRevenueCurrent 223,662us-gaap_DeferredRevenueCurrent
Total Current Liabilities 7,757,831us-gaap_LiabilitiesCurrent 8,257,784us-gaap_LiabilitiesCurrent
Derivative Warrant Liability (Note 8 and 9) 1,490,858us-gaap_DerivativeLiabilitiesNoncurrent 2,635,643us-gaap_DerivativeLiabilitiesNoncurrent
Derivative Additional Investment Rights Liability (Note 8 and 9) 743,198GNBT_DerivativeAdditionalInvestmentRightsLiability 719,088GNBT_DerivativeAdditionalInvestmentRightsLiability
Total Liabilities 9,991,887us-gaap_Liabilities 11,612,515us-gaap_Liabilities
Stockholders' Deficiency (Note 8):    
9% Convertible Preferred Stock      
Common stock, $.001 par value; authorized 1,500,000,000 shares at October 31, 2014 and July 31, 2014, respectively; 789,848,649 and 778,512,092 issued and outstanding at October 31, 2014 and July 31, 2014, respectively 66,369us-gaap_CommonStockValue 778,512us-gaap_CommonStockValue
Additional paid-in capital 362,420,085us-gaap_AdditionalPaidInCapitalCommonStock 362,307,678us-gaap_AdditionalPaidInCapitalCommonStock
Accumulated deficit (370,410,615)us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage (369,948,322)us-gaap_DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
Accumulated other comprehensive income 803,309us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax 772,074us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Total Stockholders' Deficiency (6,395,683)us-gaap_StockholdersEquity (6,090,058)us-gaap_StockholdersEquity
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY 3,596,204us-gaap_LiabilitiesAndStockholdersEquity 5,522,457us-gaap_LiabilitiesAndStockholdersEquity
Series A Convertible Preferred Stock    
Stockholders' Deficiency (Note 8):    
9% Convertible Preferred Stock      
Series B Convertible Preferred Stock    
Stockholders' Deficiency (Note 8):    
9% Convertible Preferred Stock      
Series C Convertible Preferred Stock    
Stockholders' Deficiency (Note 8):    
9% Convertible Preferred Stock      
Series D Convertible Preferred Stock    
Stockholders' Deficiency (Note 8):    
9% Convertible Preferred Stock      
Series E Convertible Preferred Stock    
Stockholders' Deficiency (Note 8):    
9% Convertible Preferred Stock      
Series F Convertible Preferred Stock    
Stockholders' Deficiency (Note 8):    
9% Convertible Preferred Stock